Darl Pharmaceutical Limited, now Curist Pharma Limited is a fast-growing pharmaceutical wholesaler and trading company which has a goal of becoming a top 3 pharmaceutical company in Ghana. The Company started in 2010 as a distributor of branded extemporaneous products then being produced by Darl Chemical Industries Limited. It, however, opened its doors to the public in January 2012 with its wholesale pharmacy outlet in Madina, Accra, Ghana.
In 2012, Curist Pharma Limited undertook its first retail pharmacy acquisition, and is the sole distributor for Candinil Capsules (Fluconazole), Neoglobin Syrup & Capsules, Plan 2 Emergency Contraceptive
Synergy Capital Managers Limited (SCML) was going to invest in Curist Pharma Limited. In order to understand the nature of environmental, social and governance risks associated with the investment, SCML engaged Environmental Accord Nigeria Limited (EnvAccord), an accredited Nigerian environmental and sustainability consulting firm, to conduct an independent ESDD Assessment of Curist operational activities. Environmental Accord engaged the services of MBA Consult Limited, one of the leading safety and environment consulting firms in Ghana as the local partner to the study, and to focus on local legislation/regulations pertinent to operations/activities of Curist Pharma Limited.
SCOPE OF SERVICES
Environmental & Social Due Diligence
Darl Pharmaceutical Limited, now Curist Pharma Limited
August 2015 - September 2015
- Undertook inspection visits to the factory
- Conducted the Due Diligence on the factory in line with national regulations
- Prepared report on the assessment/study and submitted to Environmental Accord for inclusion in the final report.
- Reviewed literature on sea conservation literature on sea conservation